)
"Our laboratory is working on developing new treatments for liver diseases, based on gene transfer using one of the safest and most effective viral vectors currently in existence: the adeno-associated virus. In the next few years, we hope to obtain a clear clinical benefit in patients with rare diseases such as hyperoxaluria", Dra. Gloria González, Program Director.
Contacto |
|
Contact:
Cibeles Pinto Avda. Pío XII, 55 31008 Pamplona España +34 948 194 700 Ext. 4012 mcpinto@unav.es |